Three novel patient-derived BCR/ABL mutants show different sensitivity to second and third generation tyrosine kinase inhibitors. (Q54479081)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Three novel patient-derived BCR/ABL mutants show different sensitivity to second and third generation tyrosine kinase inhibitors. |
scientific article |
Statements
Three novel patient-derived BCR/ABL mutants show different sensitivity to second and third generation tyrosine kinase inhibitors. (English)
Sara Redaelli
Luca Mologni
Roberta Rostagno
Rocco Piazza
Monica Ceccon
Michela Viltadi
Daniel Flynn
9 October 2012
87
11
E125-8